Skip to main content

Table 2 Study population validation reference comparing disease specific to generic PROMs

From: The frequency and availability of population-specific patient reported outcome measures and minimal clinically important differences among approved drugs in Canada

PROM validated in study population

Disease specific n (%)

Generic n (%)

Total n (%)

Not validated

11 (18)

24 (56)

35

Validateda

47 (76)

15 (35)

62

No reference given

4 (6)

4 (9)

8

Total

62

43

105 (p = < 0.001)

  1. aValidation not evaluated